RecruitingPhase 3NCT07061977

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Studying Adenocarcinoma of the cervix uteri

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Cancer Institute (NCI)
Principal Investigator: Jyoti S Mayadev, M.D
NRG Oncology
Intervention: Biospecimen Collection(procedure)
Enrollment: 336 enrolled
Eligibility: 18 years · FEMALE
Timeline: 2025 – 2030

Study locations (30)

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
City of Hope Corona, Corona, California, United States
City of Hope Comprehensive Cancer Center, Duarte, California, United States
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
City of Hope at Irvine Lennar, Irvine, California, United States
UC San Diego Moores Cancer Center, La Jolla, California, United States
City of Hope Antelope Valley, Lancaster, California, United States
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
City of Hope South Pasadena, South Pasadena, California, United States
City of Hope Upland, Upland, California, United States
UCHealth University of Colorado Hospital, Aurora, Colorado, United States
UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States
Danbury Hospital, Danbury, Connecticut, United States
Norwalk Hospital, Norwalk, Connecticut, United States
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07061977 on ClinicalTrials.gov

Other trials for Adenocarcinoma of the cervix uteri

Additional recruiting or active studies for the same condition.

See all trials for Adenocarcinoma of the cervix uteri →

← Back to all trials